You are welcome to send your RFP, feasibility questionnaire or other request at info@mt.clinic

    «BioEq» recruits for patients with anemia caused by chronic renal disease to participate in a phase III clinical study.

    Study medication: Darbepoetin alfa, solution for injection

    Standard medication: Darbepoetin alfa, solution for injection

    We invite adult male and female patients.

    You can request any additional information by phone. Please contact us at 8-812-945-22-32 to learn more.

    Write a Reply or Comment

    Your email address will not be published. Required fields are marked *